3rd Annual IPF Summit
August 27 - 29, 2019 - San Diego CA USHanson Wade
georgina.fitzgerald@hansonwade.com
Phone:+44 (0)20 3141 8700
The World’s Largest Gathering of IPF Drug Developers The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics. Download the full event guide - https://ter.li/talfx6 With the 2019 conference expanding upon an even greater breadth and depth of content, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion, as together leading academia and biopharma advance the IPF drug development frontier. Last year, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging, share clinical insights, and evaluate better recapitulating disease physiology in vitro exclusively for IPF. “This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!” Ceders-Sinai Medical Center